Exploring DBS Efficacy in Treatment-refractory Tourette's Syndrome
Exploring DBS Efficacy in Treatment-refractory Tourette's Syndrome
Not yet recruiting · NCT06361004 · Registry updated 2024-04-11Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Exploring DBS Efficacy in Treatment-refractory Tourette's Syndrome | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Tourette syndrome, basal ganglia disorder, brain disorder, central nervous system disorder, hereditary disease, inherited neurodegenerative disorder, movement disorder, nervous system disorder, neurodegenerative disease, neurodevelopmental disorder, psychiatric disorder, tic disorder | Not yet recruiting | Not applicable | 2024-04-11 | NCT06361004 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Xuanwu Hospital, Beijing | 232 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Xuanwu Hospital, Capital Medical University | Beijing | China | 38 |